| Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619) |
|---|
| 04/13/2011 | EP2308833A2 Cyclic protein tyrosine kinase inhibitors |
| 04/13/2011 | EP2308825A1 Process for the preparation of an intermediate for azoxystrobin |
| 04/13/2011 | EP2308812A2 N-acylsulfonamide apoptosis promoters |
| 04/13/2011 | EP2307404A2 Cosmetic composition, compound, and cosmetic treatment method |
| 04/13/2011 | EP2307386A1 Crystalline forms of erlotinib base and erlotinib hcl |
| 04/13/2011 | EP2307385A1 2 -arylaminoquinazolines for treating proliferative diseases |
| 04/13/2011 | EP1585737B8 Uracils having a herbicidal activity |
| 04/13/2011 | EP1542978B1 Novel bio-active molecules |
| 04/13/2011 | CN1625400B 2,4-pyrimidinediamine compounds and their uses |
| 04/13/2011 | CN102015660A 2-aminoquinazoline derivative |
| 04/13/2011 | CN102014627A Fused bicyclic pyrimidine compounds as aurora kinase inhibitors |
| 04/13/2011 | CN102010375A Rosuvastatin calcium compound with stable crystal form |
| 04/13/2011 | CN102010374A Synthesis of 3,4-dihydropyrimidine-2-ketone with biodegradable ionic liquid for catalysis |
| 04/13/2011 | CN101421230B Novel phenyl-propargylether derivatives |
| 04/13/2011 | CN101340959B Process for the treatment of an aqueous mixture comprising a dipolar aprotic compound |
| 04/13/2011 | CN101056863B Process for the production of pyrimidine-5-carboxylates |
| 04/12/2011 | US7923557 Process for preparing trisubstituted pyrimidine compounds |
| 04/12/2011 | US7923446 Biaryl sulfonamides and methods for using same |
| 04/12/2011 | CA2474875C 1-[alkyl], 1-[(heteroaryl)alkyl] and 1-[(aryl)alkyl]-7-(pyrimidin-4-yl)-imidazo[1,2,-a]pyrimidin-5(1h)-one derivatives |
| 04/12/2011 | CA2426461C Nitrogen-containing aromatic derivatives |
| 04/12/2011 | CA2419768C Amino acid-derived, 7-membered cyclic sulfamides and methods of synthesizing the same |
| 04/12/2011 | CA2387107C Derivatives of dicarboxylic acid having pharmaceutical properties |
| 04/07/2011 | WO2011039344A1 Pyrimidine derivatives as protein tyrosine kinase 2 inhibitors |
| 04/07/2011 | WO2010130900A3 Triaminopyrimidine derivatives as cdc25 phosphatase inhibitors |
| 04/07/2011 | WO2010129665A3 Pyrimidine-2,4,6-triones for use in the treatment of amyotrophic lateral sclerosis |
| 04/07/2011 | WO2010111436A3 Antiviral compounds and uses thereof |
| 04/07/2011 | WO2010051926A8 Novel halogen-substituted compounds |
| 04/07/2011 | US20110082289 Nucleic Acid Labeling Compounds |
| 04/07/2011 | US20110082163 Novel uracil compound or salt thereof having human deoxyuridine triphosphatase inhibitory activity |
| 04/07/2011 | US20110082146 Compositions and methods for inhibition of the jak pathway |
| 04/07/2011 | US20110082134 1,2,3-Trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto such as diabetes and hyperglycemia |
| 04/07/2011 | US20110081365 Compounds and compositions as tlr activity modulators |
| 04/07/2011 | CA2775418A1 Pyrimidine derivatives as protein tyrosine kinase 2 inhibitors |
| 04/06/2011 | EP2306789A1 Phenyl-pyridine compounds |
| 04/06/2011 | EP2306788A1 Iridium compounds and devices made therewith |
| 04/06/2011 | EP2305687A1 Quinazoline derivatives |
| 04/06/2011 | EP2305652A2 Trisubstituted quinazolinone derivatives as vanilloid antagonists |
| 04/06/2011 | EP2305651A1 2,3,6-trisubstituted-4-pyrimidone derivatives |
| 04/06/2011 | EP2305648A1 Amide derivatives useful as glucokinase activators |
| 04/06/2011 | EP2305627A1 Tetracyclic liquid crystalline compound having lateral fluorine, liquid crystal composition and liquid crystal display element |
| 04/06/2011 | EP2303862A2 Wnt protein signalling inhibitors |
| 04/06/2011 | EP2303849A1 Substituted quinazolines |
| 04/06/2011 | EP2303848A2 Uracil derivatives and use thereof |
| 04/06/2011 | EP2303847A1 Synthesis of cyclic amidines |
| 04/06/2011 | EP2091925B1 Bicyclic heterocycles, medicaments containing said compounds, use thereof, and method for production of same |
| 04/06/2011 | EP1780197B9 5-substituted-2-phenylamino benzamides as mek inhibitors |
| 04/06/2011 | EP1219607B1 Integrase inhibitors containing aromatic heterocycle derivatives |
| 04/06/2011 | CN1858040B 5,8-disubstituted quinazoline and its preparing method and use |
| 04/06/2011 | CN102007197A Optically isotropic liquid crystalline medium, and optical element |
| 04/06/2011 | CN102007119A Method for producing pyrimidine compound |
| 04/06/2011 | CN102002004A Taltirelin intermediate and synchronizing method of taltirelin |
| 04/06/2011 | CN101287714B Dihydrogen phosphate salt of a prostaglandin d2 receptor antagonist |
| 04/05/2011 | US7919648 Lateral α-substituted acrylate compound and polymer thereof |
| 04/05/2011 | US7919528 Antibiotic; bactericides |
| 04/05/2011 | US7919490 6-substituted 2-(benzimidazolyl)purine and purinone derivatives for immunosuppression |
| 04/05/2011 | CA2574822C Quinazoline derivatives and their use in the treatment of thrombocythemia |
| 04/05/2011 | CA2475434C Aromatic amino acid derivatives and medicinal compositions |
| 03/31/2011 | WO2011037192A1 Substituted amide compound |
| 03/31/2011 | WO2011036505A1 New 6-substituted pyrimidine derivatives |
| 03/31/2011 | WO2011036074A1 Aminoquinazoline compounds for combating invertebrate pests |
| 03/31/2011 | WO2011035518A1 Pyrimidine derivatives and analogs, preparation method and use thereof |
| 03/31/2011 | WO2010117435A3 No-carrier-added nucleophilic [f-18] fluorination of aromatic compounds |
| 03/31/2011 | WO2010088408A3 Subunit selective nmda receptor antagonists for the treatment of neurological conditions |
| 03/31/2011 | US20110077403 Regioselective preparation of substituted pyrimidines |
| 03/31/2011 | US20110077256 Mediators of hedgehog signaling pathways, compositions and uses related thereto |
| 03/31/2011 | US20110077252 Pyridyl derivatives, their preparation and use |
| 03/31/2011 | US20110077246 Bicyclic heterocyclic compounds pharmaceutical compositions containing these compounds, their use and process for preparing the same |
| 03/31/2011 | US20110077245 Substituted 2-alkyl quinazolinone derivatives as parp inhibitors |
| 03/31/2011 | US20110077242 Diaminopyrimidines as p2x3 and p2x2/3 antagonists |
| 03/31/2011 | US20110077233 C-Met Modulators and Method of Use |
| 03/31/2011 | US20110077156 Herbicidal pyrimidines |
| 03/31/2011 | US20110077153 Substituted Heteroarylmethyl Sulfonamides |
| 03/31/2011 | US20110076286 Methods of inhibiting unwanted cell proliferation using hedgehog antagonists |
| 03/31/2011 | US20110076276 Novel HIV reverse transcriptase inhibitors |
| 03/31/2011 | CA2774647A1 Substituted amide compound |
| 03/30/2011 | EP2302015A1 Optically isotropic liquid crystalline medium, and optical element |
| 03/30/2011 | EP2301923A1 New compounds |
| 03/30/2011 | EP2300441A1 Crystalline salt forms of antifolate compounds and methods of manufacturing thereof |
| 03/30/2011 | EP2300440A1 3,4-dihydropyrimidine trpa1 antagonists |
| 03/30/2011 | EP2300434A1 Dihydropyrazole derivatives as tyrosine kinase modulators for the treatment of tumors |
| 03/30/2011 | EP2300430A1 Benzene or thiophene derivative and use thereof as vap-1 inhibitor |
| 03/30/2011 | EP2299823A1 Pyrimidine non-classical cannabinoid compounds and related methods of use |
| 03/30/2011 | EP1742927B1 Butanoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and therapeutic applications threreof |
| 03/30/2011 | EP1650196B1 Process for producing 6,7-bis(2-methoxyethoxy)-quinazolin-4-one |
| 03/30/2011 | EP1277738B1 Condensed heteroaryl derivatives |
| 03/30/2011 | CN101993420A Preparation method of 4-[(4,6-dihydroxyl-2-pyrimidinyl)amino] cyanobenzene |
| 03/30/2011 | CN101993419A Preparation method of 4-[(5-bromo-4,6-dichloro-2-pyrimidinyl)amino] cyanobenzene |
| 03/29/2011 | US7915412 Reacting 3-(2-chloroethyl)-6,7,8,9-tetrahydro-9-hydroxy-2-methyl-4H-pyrrido[1,2-a]-pyrimidin-4-one, and 6-fluoro-3-piperidino-1,2-benisoxazol, in the presence of an inorganic base. |
| 03/29/2011 | US7915293 Carbocyclic and heterocyclic sulfonamide derivatives, e.g., N-(2-bromo-5-(trifluoromethoxy)phenyl)-3,5-dichloro-4-(2-chloro-4-nitrophenoxy)benzenesulfonamide and 4-(2-(trifluoromethyl)phenoxy)-1-(3-trifluoromethyl)phenylsulfonyl)piperidine; treating proliferative diseases |
| 03/29/2011 | US7915273 Compositions and methods for inhibition of the JAK pathway |
| 03/29/2011 | US7915271 1,3-oxazolidin-2-one derivatives useful as CETP inhibitors |
| 03/29/2011 | US7915251 Alpha-helix mimetics and methods relating to the treatment of fibrosis |
| 03/29/2011 | US7915200 2-(2-fluoro-substituted phenyl)-6-amino-5-chloro-4-pyrimidinecarboxylates and their use as herbicides |
| 03/24/2011 | WO2011034078A1 Glycine compound |
| 03/24/2011 | WO2011032656A1 5-fluor-2-thio-substituted pyrimidine derivatives |
| 03/24/2011 | WO2011032277A1 Quinazolinone derivatives as viral polymerase inhibitors |
| 03/24/2011 | WO2010140765A3 Novel method for preparing rosuvastatin, intermediate compounds useful for preparing same, and method for preparing same |
| 03/24/2011 | US20110071290 Process And Catalyst |
| 03/24/2011 | US20110071174 Substituted quinazolines |
| 03/24/2011 | US20110071173 Imidazoquinazoline derivatives as anagrelide analogues for the treatment of myeloprolific diseases and thrombotic diseases |